LifeMD (LFMD) Cash from Investing Activities (2018 - 2025)

LifeMD's Cash from Investing Activities history runs 8 years deep, the most recent figure standing at $17.1 million for Q4 2025.

• Quarterly Cash from Investing Activities rose 2682.37% year-over-year to $17.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.9 million (up 184.23% YoY) and the FY2025 annual result came in at $6.9 million, up 184.23% from the prior year.
• Cash from Investing Activities was $17.1 million for Q4 2025 at LifeMD, up from -$3.6 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $17.1 million in Q4 2025 and bottomed at -$7.4 million in Q1 2022.
• A 5-year average of -$1.4 million and a median of -$2.2 million in 2022 frame the typical range for Cash from Investing Activities.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities tumbled 15000.67% — and 2025, when it surged 2682.37%.
• LifeMD's Cash from Investing Activities stood at -$1.6 million in 2021, then declined by 12.2% to -$1.8 million in 2022, then slipped by 25.16% to -$2.2 million in 2023, then jumped by 127.68% to $613492.0 in 2024, then jumped by 2682.37% to $17.1 million in 2025.
• Business Quant data shows LFMD's Cash from Investing Activities at $17.1 million in Q4 2025, -$3.6 million in Q3 2025, and -$3.7 million in Q2 2025.